Andriana Ι. Papaioannou

ORCID: 0000-0001-9708-3241
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Inhalation and Respiratory Drug Delivery
  • Neonatal Respiratory Health Research
  • IL-33, ST2, and ILC Pathways
  • Pediatric health and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Long-Term Effects of COVID-19
  • Pulmonary Hypertension Research and Treatments
  • Sarcoidosis and Beryllium Toxicity Research
  • Eosinophilic Esophagitis
  • Pleural and Pulmonary Diseases
  • COVID-19 Clinical Research Studies
  • Medical Imaging and Pathology Studies
  • Obstructive Sleep Apnea Research
  • Venous Thromboembolism Diagnosis and Management
  • Intensive Care Unit Cognitive Disorders
  • Occupational and environmental lung diseases
  • Pharmaceutical studies and practices
  • Occupational exposure and asthma
  • Ultrasound in Clinical Applications
  • Nutrition and Health in Aging

National and Kapodistrian University of Athens
2016-2025

Sotiria General Hospital
2022-2025

e-Trikala (Greece)
2024

Respiratory Clinical Trials
2023

University General Hospital Attikon
2015-2022

Centre Eugène Marquis
2022

Université de Rennes
2022

Inserm
2022

Sismanoglio General Hospital
2011-2021

Translational Research Institute
2021

Pulmonary rehabilitation (PR) remains grossly underutilised by suitable patients worldwide. We investigated whether home-based maintenance tele-rehabilitation will be as effective hospital-based and superior to usual care in reducing the risk for acute chronic obstructive pulmonary disease (COPD) exacerbations, hospitalisations emergency department (ED) visits. Following completion of an initial 2-month PR programme this prospective, randomised controlled trial (between December 2013 July...

10.1183/13993003.02129-2016 article EN European Respiratory Journal 2017-05-01

Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe cohorts.What is the prevalence phenotypes population asthma, can these be differentiated by clinical biomarker variables?This was an historical registry study. Adult available blood eosinophil count (BEC) from 11 countries enrolled International Severe Asthma Registry (January 1, 2015-September 30, 2019) were categorized according to likelihood phenotype...

10.1016/j.chest.2021.04.013 article EN cc-by-nc-nd CHEST Journal 2021-04-19
John W. Upham Chantal Le Lievre David J. Jackson Matthew Masoli Michael E. Wechsler and 95 more David Price Adel Mansur Aikaterini Detoraki Alan Altraja Alan L. James Alexandra Nanzer-Kelly Andréanne Côté Andrew Menzies‐Gow Andriana Ι. Papaioannou Anne-Maree Cheffins Arnaud Bourdin Bassam Mahboub Brian J. Lipworth C.A. Celis-Preciado Carlos A. Torres‐Duque Caterina Bucca Celeste Porsbjerg Charlotte Suppli Ulrik Christopher J. Corrigan Christian Taube Claude S. Farah Constance H. Katelaris David Langton Dermot Ryan Désirée Larenas‐Linnemann Εleftherios Ζervas Enrico Heffler Flavia Hoyte Francesca Puggioni George Christoff Giorgio Walter Canonica Giovanna Elisiana Carpagnano Giuseppe Guida Gregory Katsoulotos Guy Brusselle Hitashi Rupani Hubertus Jersmann I. Clifton Jaideep Dhariwal James Fingleton Jane Duke Janet Rimmer John Aubrey Douglass João Fonseca Job F. M. van Boven John Corless John Harrington Jorge Máspero José Luís San Miguel Kanok Pipatvech Karrinda Kenny Kenneth R. Chapman Κonstantinos Κostikas Lauri Lehtimäki Li Ping Chung Liam G. Heaney Liang‐Wen Hang Louis‐Philippe Boulet Luis Pérez de Llano L Ricciardi Majdy Idrees Manlio Milanese Maria Elisabetta Conte Maria Teresa Costantino Mariko Koh Siyue Mark Fitzgerald Mark Hew Matthew Peters Ming‐Ju Tsai Mitesh Patel Mohammad Hashim Khan Mohsen Sadatsafavi Mona Al‐Ahmad Mona‐Rita Yacoub Mónica De Gennaro Naghmeh Radhakrishna Nicola A. Hanania Nikolaos G. Papadopoulos Njira Lugogo Norma Linaker Nunzio Crimi Paddy Dennison Parameswaran Nair Patrick Mitchell Paul M. O’Byrne Paul Pfeffer Paula Kauppi Pauline Hughes Peter G. Middleton Peter Wark Philip Bardin Pin‐Kuei Fu Praveen Akuthota Rekha Chaudhuri R. Diaz Campos

10.1016/j.jaip.2021.06.041 article EN The Journal of Allergy and Clinical Immunology In Practice 2021-07-13

Abstract Sirtuin-1 (SIRT1) and SIRT6, NAD + -dependent Class III protein deacetylases, are putative anti-aging enzymes, down-regulated in patients with chronic obstructive pulmonary disease (COPD), which is characterized by the accelerated ageing of lung associated increased oxidative stress. Here, we show that stress (hydrogen peroxide) selectively elevates microRNA-34a (miR-34a) but not related miR-34b/c, concomitant reduction SIRT1/-6 bronchial epithelial cells (BEAS2B), was also observed...

10.1038/srep35871 article EN cc-by Scientific Reports 2016-10-21

International registries provide opportunities to describe use of biologics for treating severe asthma in current clinical practice. Our aims were real-life global patterns biologic (continuation, switches, and discontinuations) asthma, elucidate reasons underlying these patterns, examine associated patient-level factors.This was a historical cohort study including adults with enrolled into the Severe Asthma Registry (ISAR; http://isaregistries.org, 2015-2020) or CHRONICLE Study (2018-2020)...

10.2147/jaa.s328653 article EN cc-by-nc Journal of Asthma and Allergy 2022-01-01
Michael E. Wechsler Ghislaine Scélo Désirée Larenas‐Linnemann Carlos A. Torres‐Duque Jorge Máspero and 81 more Trung N. Tran Ruth Murray Neil Martin Andrew Menzies‐Gow Mark Hew Matthew Peters Peter G. Gibson George Christoff Todor A. Popov Andréanne Côté Céline Bergeron Delbert R. Dorscheid J Mark FitzGerald Kenneth R. Chapman Louis Philippe Boulet Mohit Bhutani Mohsen Sadatsafavi Libardo Jiménez-Maldonado Mauricio Durán-Silva Bellanid Rodriguez C.A. Celis-Preciado Diana Jimena Cano Rosales Iván Solarte María José Fernández Sánchez Patricia Parada-Tovar Anna von Bülow Anne Sofie Bjerrum Charlotte Suppli Ulrik Karin Dahl Assing Linda Rasmussen Susanne Hansen Alan Altraja Arnaud Bourdin Camille Taillé Jérémy Charriot Nicolás Roche Andriana Ι. Papaioannou Κonstantinos Κostikas Nikolaos G. Papadopoulos Sundeep Salvi Deirdre Long Patrick Mitchell Richard W. Costello Concetta Sirena Cristina Cardini Enrico Heffler Francesca Puggioni Giorgio Walter Canonica Giuseppe Guida Takashi Iwanaga Mona Al‐Ahmad Ulises Román Martínez García Piotr Kuna João Fonseca Riyad Al‐Lehebi Mariko Siyue Koh Chin Kook Rhee Borja G. Cosío Luís Pérez de Llano Diahn-Warng Perng Erick Wan-Chun Huang Hao‐Chien Wang Ming‐Ju Tsai Bassam Mahboub Laila Salameh D.J. Jackson John Busby Liam G. Heaney Paul Pfeffer Amanda Grippen Goddard Eileen Wang Flavia Hoyte Nicholas Chapman Rohit Katial Victoria Carter Lakmini Bulathsinhala Neva Eleangovan Con Ariti Juntao Lyu Celeste Porsbjerg David Price

Previous studies investigating the impact of comorbidities on effectiveness biologic agents have been relatively small and short duration not compared classes agents.

10.1164/rccm.202305-0808oc article EN cc-by-nc-nd American Journal of Respiratory and Critical Care Medicine 2023-11-28

COPD is a major healthcare problem and cause of mortality worldwide. patients at increased risk are those who more symptomatic, have lower lung function diffusing capacity the for carbon monoxide, decreased exercise capacity, belong to emphysematous phenotype concomitant bronchiectasis. Mortality seems be greater in experience exacerbations suffer from cardiovascular and/or metabolic diseases. To predict death patients, several composite scores been created using different parameters. In...

10.1183/23120541.00850-2023 article EN cc-by-nc ERJ Open Research 2024-03-07

Background To date, studies investigating the association between pre-biologic biomarker levels and post-biologic outcomes have been limited to single biomarkers assessment of biologic efficacy from structured clinical trials. Aim elucidate associations individual or their combinations with pre-to-post changes in asthma real-life. Methods This was a registry-based, cohort study using data 23 countries, which shared International Severe Asthma Registry (May 2017-February 2023). The...

10.3389/fimmu.2024.1361891 article EN cc-by Frontiers in Immunology 2024-04-19

The International Severe Asthma Registry (ISAR) was established in 2017 to advance the understanding of severe asthma and its management, thereby improving patient care worldwide. As first global registry for adults with asthma, ISAR enabled individual registries standardize pool their data, creating a comprehensive, harmonized dataset sufficient statistical power address key research questions knowledge gaps. Today, is largest repository real-world data on curating nearly 35,000 patients...

10.4046/trd.2024.0198 article EN cc-by-nc Tuberculosis & respiratory diseases 2025-02-06

Serum uric acid is increased in respiratory disease, especially the presence of hypoxia and systemic inflammation. We evaluated serum as a biomarker for prediction mortality future acute exacerbation chronic obstructive pulmonary disease (AECOPD). was measured 314 eligible consecutive patients on admission AECOPD. Patients were monthly 1 year. Uric levels higher with more severe airflow limitation those experiencing frequent exacerbations. High (≥6.9 mg·dL(-1)) an independent predictor...

10.1183/09031936.00209212 article EN European Respiratory Journal 2013-05-03

According to induced sputum cell count, four different asthma phenotypes have been recognized (eosinophilic, neutrophilic, mixed and paucigranulocytic). The aim of this study was detect functional inflammatory characteristics patients with paucigranulocytic asthma.A total 240 asthmatic were categorized into the according counts in sputum. All underwent pulmonary function tests, measurement fraction exhaled nitric oxide (FeNO). levels IL-8, IL-13 eosinophilic cationic protein (ECP) also...

10.1111/all.13184 article EN Allergy 2017-04-13

The impact of depressive symptoms on outcomes acute exacerbations chronic obstructive pulmonary disease (AECOPD) has not been thoroughly evaluated in prospective studies. We prospectively enrolled 230 consecutive patients hospitalised for AECOPD, without previous diagnosis depression. Depressive were with Beck's depression inventory. Pulmonary function tests, arterial blood gases, COPD assessment test (CAT) and Borg dyspnoea scale recorded admission days 3, 10 40. Patients monthly 1 year....

10.1183/09031936.00013112 article EN European Respiratory Journal 2012-08-09

Idiopathic pulmonary fibrosis acute exacerbation (IPF-AE) constitutes IPF's most devastating event, representing the unexpected superimposition of diffuse alveolar damage unknown etiology. Guidelines recommend high-dose steroids treatment despite unproven benefit. We hypothesized that previous immunosuppression and administration adversely affect IPF-AE outcome. studied all consecutive patients hospitalized in our department for IPF deterioration from 2007 to June 2013. Our protocol...

10.1186/s12890-015-0146-4 article EN cc-by BMC Pulmonary Medicine 2015-12-01
Ghislaine Scélo Carlos A. Torres‐Duque Jorge Máspero Trung N. Tran Ruth Murray and 81 more Neil Martin Andrew Menzies‐Gow Mark Hew Matthew Peters Peter G. Gibson George Christoff Todor A. Popov Andréanne Côté Céline Bergeron Delbert R. Dorscheid J. Mark FitzGerald Kenneth R. Chapman Louis Philippe Boulet Mohit Bhutani Mohsen Sadatsafavi Libardo Jiménez-Maldonado Mauricio Durán-Silva Bellanid Rodriguez C.A. Celis-Preciado Diana Jimena Cano Rosales Iván Solarte María José Fernández Sánchez Patricia Parada-Tovar Anna von Bülow Anne Sofie Bjerrum Charlotte Suppli Ulrik Karin Dahl Assing Linda Rasmussen Susanne Hansen Alan Altraja Arnaud Bourdin Camille Taillé Jérémy Charriot Nicolás Roche Andriana Ι. Papaioannou Κonstantinos Κostikas Nikolaos G. Papadopoulos Sundeep Salvi Deirdre Long Patrick Mitchell Richard W. Costello Concetta Sirena Cristina Cardini Enrico Heffler Francesca Puggioni Giorgio Walter Canonica Giuseppe Guida Takashi Iwanaga Mona Al‐Ahmad Désirée Larenas‐Linnemann Ulises Román Martínez García Piotr Kuna João Fonseca Riyad Al‐Lehebi Mariko Siyue Koh Chin Kook Rhee Borja G. Cosío Luis Pérez de Llano Diahn-Warng Perng Erick Wan-Chun Huang Hao‐Chien Wang Ming-Ju Tsai Bassam Mahboub Laila Salameh D.A. Jackson John Busby Liam G. Heaney Paul Pfeffer Amanda Grippen Goddard Eileen Wang Flavia Hoyte Michael E. Wechsler Nicholas Chapman Rohit Katial Victoria Carter Lakmini Bulathsinhala Neva Eleangovan Con Ariti Juntao Lyu David Price Celeste Porsbjerg

BackgroundInvestigation for the presence of asthma comorbidities is recommended by GINA as their can complicate management.ObjectiveTo understand prevalence and pattern multimorbidity in adults with severe association asthma-related outcomes.MethodsThis was a cross-sectional study using data from International Severe Asthma Registry 22 countries. Thirty were identified categorized priori either (1) potentially T2-related, (2) oral corticosteroid (OCS)-related or (3) mimicking/aggravating...

10.1016/j.anai.2023.08.021 article EN cc-by-nc-nd Annals of Allergy Asthma & Immunology 2023-08-26

BACKGROUND Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS), nor compared to effectiveness continuing HOCS alone. OBJECTIVE To examine the initiating a large, real-world cohort adult severe asthma and HOCS. METHODS This was propensity-score-matched, prospective study using data from International Severe Asthma Registry (http://isaregistries.org/). Between January 2015 February 2021, (long-term OCS ≥1 year or ≥4 courses rescue...

10.1016/j.jaip.2023.05.044 article EN cc-by-nc-nd The Journal of Allergy and Clinical Immunology In Practice 2023-06-08

Evidence from large epidemiological studies has shown that obesity may predispose to increased Th2 inflammation and increase the odds of developing asthma. On other hand, there is growing evidence suggesting metabolic dysregulation occurs with obesity, more specifically hyperglycemia insulin resistance, modify immune cell function in some degree systemic inflammation. Insulin resistance seldom on its own, most cases constitutes a clinical component syndrome, along central dyslipidemia....

10.3390/biomedicines12020437 article EN cc-by Biomedicines 2024-02-16

Pleural effusion is a common complication of various diseases. Conventional methods are not always capable establishing the cause pleural effusion, so alternative tests needed. The aim this study was to explore means discriminating between different groups, malignant, parapneumonic and tuberculous, based on combined function seven biological markers. Adenosine deaminase (ADA), interferon-γ, C-reactive protein (CRP), carcinoembryonic antigen, interleukin-6, tumour necrosis factor-α vascular...

10.1183/09031936.00126306 article EN European Respiratory Journal 2007-08-09

The association between systemic sclerosis and pulmonary arterial hypertension (PAH) is well recognized. Vascular endothelial growth factor (VEGF) has been reported to play an important role in hypertension. aim of the present study was examine relationship systolic artery pressure, clinical functional manifestations disease serum VEGF levels sclerosis. Serum were measured 40 patients with 13 control subjects. All underwent examination, function tests echocardiography. higher sPAP ≥ 35 mmHg...

10.1186/1471-2466-9-18 article EN cc-by BMC Pulmonary Medicine 2009-05-09
Coming Soon ...